24-Hour ambulatory blood pressure control with triple-therapy amlodipine, valsartan and hydrochlorothiazide in patients with moderate to severe hypertension.
To determine the effectiveness and safety of once-daily combination therapy with amlodipine, valsartan and hydrochlorothiazide for reducing ambulatory blood pressure (ABP) in patients with moderate to severe hypertension, a multicenter, double-blind study was performed (N=2271) that included ABP monitoring in a 283-patient subset. After a single-blind, placebo run-in period, patients were randomized to receive amlodipine/valsartan/hydrochlorothiazide (10/320/25 mg), valsartan/hydrochlorothiazide (320/25 mg), amlodipine/valsartan (10/320 mg) or amlodipine/hydrochlorothiazide (10/25 mg) each morning for 8 weeks. Efficacy assessments included change from baseline in 24-h, daytime and night time mean ambulatory systolic BP (SBP) and diastolic BP (DBP). Statistically significant and clinically relevant reductions from baseline in all these parameters occurred in all treatment groups (P<0.0001, all comparisons versus baseline). At week 8, least squares mean reductions from baseline in 24-h, daytime and night time mean ambulatory SBP/DBP were 30.3/19.7, 31.2/20.5 and 28.0/17.8 mm Hg, respectively, with amlodipine/valsartan/hydrochlorothiazide; corresponding reductions with dual therapies ranged from 18.8-24.1/11.7-15.5, 19.0-25.1/12.0-16.0 and 18.3-22.6/11.1-14.3 mm Hg (P≤0.01, all comparisons of triple versus dual therapy). Treatment with amlodipine/valsartan/hydrochlorothiazide maintained full 24-h effectiveness, including during the morning hours; all hourly mean ambulatory SBP and mean ambulatory DBP measurements were ≤130/85 mm Hg at end point. Amlodipine/valsartan/hydrochlorothiazide combination therapy was well tolerated. Once-daily treatment with amlodipine/valsartan/hydrochlorothiazide (10/320/25 mg) reduces ABP to a significantly greater extent than component-based dual therapy and maintains its effectiveness over the entire 24-h dosing period.
Hypertension Research Unit, Centre Hospitalier Universitaire de Québec, Québec, Canada. yves.lacourciere@crchul.ulaval.ca
Y
Y
Lacourcière
N
N
Crikelair
R D
RD
Glazer
J
J
Yen
D A
DA
Calhoun
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017311:Amlodipine / Q000008:administration & dosage; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D018660:Blood Pressure Monitoring, Ambulatory; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006852:Hydrochlorothiazide / Q000008:administration & dosage; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000008:administration & dosage; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000068756:Valsartan
D000959:Antihypertensive Agents; D013777:Tetrazoles; D006852:Hydrochlorothiazide; D017311:Amlodipine; D000068756:Valsartan; D014633:Valine
Am J Hypertens. 2005 Jan;18(1):56-64
15691618
Geriatrics. 2007 Aug;62(8):11-4
17668959
J Hypertens. 2008 Jul;26(7):1290-9
18550999
BMJ. 2004 Mar 13;328(7440):634-40
15016698
Cardiovasc Diabetol. 2007 Oct 02;6:28
17910747
J Hypertens. 2007 Jun;25(6):1105-87
17563527
Int Heart J. 2007 Mar;48(2):177-86
17409583
Hypertension. 2003 Dec;42(6):1206-52
14656957
Acta Physiol Scand. 1990 May;139(1):47-53
2141447
Am J Hypertens. 1999 Dec;12(12 Pt 3):205S-213S
10619573
Blood Press Monit. 1999 Dec;4(6):319-31
10602536
JAMA. 2003 Dec 3;290(21):2805-16
14657064
Lancet. 1978 Apr 15;1(8068):795-7
85815
Am Heart J. 2008 Aug;156(2):241-7
18657652
J Int Med Res. 2005 Nov-Dec;33(6):620-31
16372579
Am J Geriatr Cardiol. 2006 May-Jun;15(3):151-60
16687967
Blood Press Monit. 1999;4 Suppl 2:S9-S16
10822417
Lancet. 2002 Mar 23;359(9311):995-1003
11937178
Hypertension. 1995 Jul;26(1):55-9
7607733
Am J Manag Care. 2005 Sep;11(7 Suppl):S220-7
16180960
Hypertension. 2009 Jul;54(1):32-9
19470877
JAMA. 2003 Apr 23-30;289(16):2073-82
12709465
J Clin Hypertens (Greenwich). 2006 Aug;8(8):584-9
16896274
Blood Press Monit. 2009 Jun;14(3):112-20
19384192
Rev Port Cardiol. 2005 Sep;24(9):1059-72
16335281
JAMA. 2002 Nov 20;288(19):2421-31
12435255
Clin Ther. 2005 Nov;27(11):1795-805
16368450
Blood Press Monit. 2002 Apr;7(2):111-6
12048428
Int J Clin Pract. 2003 May;57(4):273-9
12800457
J Clin Hypertens (Greenwich). 2002 Nov-Dec;4(6):393-404
12461301
N Engl J Med. 2008 Dec 4;359(23):2417-28
19052124
J Manag Care Pharm. 2007 Oct;13(8 Suppl B):34-9
17970615